Henry Schein Inc (HSIC) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.

Total Revenue Chart for Henry Schein Inc

Henry Schein Inc (HSIC) revenue for FY2025 was USD 13.2B, a 4.0% change from FY2024. Henry Schein Inc's revenue grew from USD 486.6M in 1994 to USD 13.2B in 2025 (2609.4% over 31 years). Earnings per share grew from USD 0.17 in 2000 to USD 3.91 in 2022 (2246.7%). Revenue compound annual growth rate: 5-year CAGR of 5.4%, 10-year CAGR of 2.2%, 20-year CAGR of 5.4%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$10.05B
Implied Share Price
$88.23
Enterprise Value
$13.81B
Revenue (TTM)
$13.60B
EBITDA
$1.08B
Profit Margin
2.96%
Trailing P/E
26.10
Forward P/E
16.67
Price/Book (MRQ)
3.22
Price/Sales (TTM)
0.74
EV/EBITDA
13.67
EV/Revenue
1.02
Dividend Yield
—
Book Value
$28.21
Free Cash Flow (FY2025)
$573.00M
Free Cash Flow Yield
5.70%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.